CompletedPHASE1, PHASE2NCT00621192
Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections
Studying Necrotizing enterocolitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Emmes Company, LLC
- Principal Investigator
- Danny Benjamin, MD, PhD, MPHDuke University
- Intervention
- meropenem(drug)
- Enrollment
- 200 target
- Eligibility
- All sexes
- Timeline
- 2008 – 2009
Study locations (26)
- University of Alabama, Birmingham, Alabama, United States
- Children's Hospital of Oakland, Oakland, California, United States
- Children's Hospital of Orange County, Orange, California, United States
- University of California Medical Center, San Diego, California, United States
- Sharp-Mary Birch Hospital for Women, San Diego, California, United States
- Yale New Haven Hospital, New Haven, Connecticut, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- University of Florida, Gainesville, Florida, United States
- Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States
- Evanston Northwestern Healthcare, Evanston, Illinois, United States
- Indiana University - Riley Hospital for Children, Indianapolis, Indiana, United States
- University of Louisville, Louisville, Kentucky, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Kansas City Children's Mercy Hospital, Kansas City, Missouri, United States
- Albany Medical Center, Albany, New York, United States
- +11 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00621192 on ClinicalTrials.govOther trials for Necrotizing enterocolitis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07490834Long-term Nutritional Impact of Necrotizing Enterocolitis in Premature Newborns.Central Hospital, Nancy, France
- RECRUITINGNCT07192393Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).Imperial College London
- RECRUITINGNANCT06727877Predictive Diagnosis of Ulcero-Necrotizing EnteroColitis in Premature Babies Using an Artificial Intelligence Approach Based on Early Analysis of the Fecal MicrobiotaUniversity Hospital, Clermont-Ferrand
- RECRUITINGNCT06681129Study of Normal Intestinal Development and Disease in Premature and Term NeonatesBoston Children's Hospital
- ACTIVE NOT RECRUITINGNCT06850896Antibiotic Exposure on Gut Microbiota and Motility Establishment in NewbornsThe First Hospital of Jilin University
- RECRUITINGNCT07152106Amniotic Fluid & the Preterm GutMaxima Medical Center
- RECRUITINGNANCT06672913Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter StudyBaskent University Ankara Hospital
- ACTIVE NOT RECRUITINGNANCT06908239Milk Temperature Control and Necrotizing Enterocolitis Risk in Extremely Preterm InfantsDaping Hospital and the Research Institute of Surgery of the Third Military Medical University